Inventor
FISCHER JENS
CH34 patents
⚠️ This page may combine multiple inventors who share the name “FISCHER JENS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOFFMANN LA ROCHE
14 patentsUS9714292B2Jul 25, 2017
Bispecific antibodies against human TWEAK and human IL17 and uses thereof
HOFFMANN LA ROCHE21 citations93
US11285207B2Mar 29, 2022
Bispecific antibodies specifically binding to PD1 and LAG3
HOFFMANN LA ROCHE10 citations83
US9309319B2Apr 12, 2016
Antibodies against human IL33R and uses thereof
HOFFMANN LA ROCHE8 citations83
US10287352B2May 14, 2019
Bispecific antibodies specific for PD1 and TIM3
HOFFMANN LA ROCHE10 citations82
US10718762B2Jul 21, 2020
Cellular based fret assay for the determination of simultaneous binding
HOFFMANN LA ROCHE5 citations73
US11130810B2Sep 28, 2021
Bispecific antibodies specific for PD1 and TIM3
HOFFMANN LA ROCHE4 citations71
US10434184B2Oct 8, 2019
Anti-TPBG antibodies and methods of use
HOFFMANN LA ROCHE3 citations70
US10329346B2Jun 25, 2019
TNFa-IL-17 bispecific antibodies
HOFFMANN LA ROCHE1 citations62
US12391757B2Aug 19, 2025
Bispecific antibodies specific for PD1 and TIM3
HOFFMANN LA ROCHE0 citations61
US12103967B2Oct 1, 2024
Bispecific anti-CCL2 antibodies
HOFFMANN LA ROCHE0 citations56
US11981737B2May 14, 2024
Anti-HLA-G antibodies and use thereof
HOFFMANN LA ROCHE0 citations56
US11739142B2Aug 29, 2023
Bispecific anti-CCL2 antibodies
HOFFMANN LA ROCHE1 citations56
US12157770B2Dec 3, 2024
Anti-HLA-G antibodies and methods of use thereof
HOFFMANN LA ROCHE0 citations48
US12258371B2Mar 25, 2025
Stabilized immunoglobulin domains
HOFFMANN LA ROCHE0 citations47